Our Recommendations
- Tropical Medicine Point-of-Care Testing. Update 2022 (2022)
- Technology and Market Landscape Hepatitis C Medicines, August 2017 (2017)
- Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases (2020)
- Zika virus (ZIKV) Surveillance in the Americas: Laboratory detection and diagnosis (2016)
- Laboratory Guidance for the Diagnosis of Ebola Virus Disease (2014)
New Publications
- Tropical Medicine Point-of-Care Testing. Update 2022 (2022)
- Séquençage génomique du SARS-CoV-2 à des fins de santé publique : orientations provisoires, 8 janvier 2021 (2021)
- Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection (2022)
- SARS-CoV-2 genomic sequencing for public health goals: Interim guidance, 8 January 2021 (2021)
- Genomic sequencing of SARS-CoV-2: a guide to implementation for maximum impact on public health (2021)
Filter
29
Featured
Recommendations
14
New Publications
7
Language
Document type
Guidelines
13
No document type
12
Manuals
2
Resource Platforms
1
Fact sheets
1
Countries / Regions
Africa
3
Latin America and the Carribbean
3
East and Southern Africa
3
Sierra Leone
2
Liberia
2
Ghana
1
Nigeria
1
Mozambique
1
Germany
1
West and Central Africa
1
Angola
1
Authors & Publishers
Publication Years
Category
Toolboxes
Diagnostics & Laboratory Guidance
14
Country specific documents
6
Laboratory Guidance
5
Genomic sequencing
4
Laboratory & Sampling
2
Zika
2
Laboratory & Diagnostics
2
Rapid Response
1
HIV testing & services
1
Clinical Aspects, Treatment & Prevention
1
Yellow Fever
1
Yellow Fever Prevention & Control
1
Public Health
1
Laboratory
1
Laboratory
1
Clinical Aspects
1
Scientific & Research Studies
1
MPOX - Monkeypox
1
Access to treatment and laboratory
1
Laboratory
1
To meet the need for laboratory diagnosis to be integrated in community care, the new 2022 Update describes point-of-care tests that can be performed both in district laboratories and peripheral healthcare facilities by non-specialist staff. Also included are recently developed self-tests.
Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection
recommended
Policy Brief. 24 June 2022. This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommendations include decentralization, integration and ta...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
8 January 2021
Sequencing enabled the world to rapidly identify SARS-CoV-2 and develop diagnostic tests and other tools for outbreak management. Continued genome sequencing supports the monitoring of the disease’s spread and evolution of the virus. Accelerated integration of genome sequencing int...
Tests zur Detektion einer Infektion mit SARS-CoV-2 (neuartiges Coronavirus) sowie zum Nachweis von Antikörpern gehören zu den sog. In-vitro-Diagnostika (IVD). Das erstmalige Inverkehrbringen von In-vitro-Diagnostika auf dem deutschen Markt ist nach §§ 25 und 30 Medizinproduktegesetz (MPG) anzeig...
8 July 2020
The speed of developing diagnostics for SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), has been quite remarkable. Diagnostics have focused on nucleic acid amplification testing (NAAT) to identify infected individuals in acute-phase disease for timely implementation of mitiga...
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China.
19 March 2020
July 2018
This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
